HomeLPGO • STO
add
Lipigon Pharmaceuticals AB
Previous close
kr 0.12
Day range
kr 0.11 - kr 0.13
Year range
kr 0.086 - kr 0.40
Market cap
16.24M SEK
Avg Volume
1.60M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.32M | — |
Operating expense | 2.50M | 16.61% |
Net income | -10.71M | -41.74% |
Net profit margin | -812.59 | — |
Earnings per share | — | — |
EBITDA | -11.88M | -49.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.78M | -63.12% |
Total assets | 14.82M | -55.89% |
Total liabilities | 7.06M | 36.96% |
Total equity | 7.76M | — |
Shares outstanding | 148.33M | — |
Price to book | 2.35 | — |
Return on assets | -166.27% | — |
Return on capital | -227.25% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.71M | -41.74% |
Cash from operations | 1.06M | 116.44% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | 1.04M | -84.53% |
Free cash flow | 4.29M | 207.90% |
About
Founded
2010
Website
Employees
6
